First Manhattan CO Vertex Pharmaceuticals Inc Transaction History

First Manhattan CO

$31.9 Billion
Q3 2024

A detailed history of First Manhattan CO transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, First Manhattan CO holds 1,570 shares of VRTX stock, worth $640,842. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,570

Previous 1,555 0.96%

Holding current value

$640,842

Previous $728,000 0.27%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$460.0 - $505.78 $6,900 - $7,586	15 Added 0.96%	1,570 $730,000
Q2 2024 Aug 13, 2024	BUY	$392.81 - $485.53 $392 - $485	1 Added 0.06%	1,555 $728,000
Q1 2024 May 15, 2024	BUY	$407.69 - $446.08 $27,722 - $30,333	68 Added 4.58%	1,554 $649,000
Q4 2023 Feb 13, 2024	SELL	$343.0 - $410.68 $25,382 - $30,390	-74 Reduced 4.74%	1,486 $604,000
Q3 2023 Nov 14, 2023	BUY	$338.18 - $362.46 $2,367 - $2,537	7 Added 0.45%	1,560 $542,000
Q2 2023 Aug 14, 2023	BUY	$314.42 - $351.91 $8,803 - $9,853	28 Added 1.84%	1,553 $546,000
Q1 2023 May 15, 2023	SELL	$283.23 - $323.1 $9,629 - $10,985	-34 Reduced 2.18%	1,525 $480,000
Q4 2022 Feb 14, 2023	BUY	$285.76 - $321.48 $2,571 - $2,893	9 Added 0.58%	1,559 $450,000
Q3 2022 Nov 14, 2022	SELL	$273.83 - $305.53 $54,766 - $61,105	-200 Reduced 11.43%	1,550 $448,000
Q2 2021 Aug 16, 2021	SELL	$187.49 - $221.1 $74,996 - $88,440	-400 Reduced 18.6%	1,750 $352,000
Q1 2021 May 14, 2021	SELL	$207.02 - $241.31 $20,702 - $24,131	-100 Reduced 4.44%	2,150 $462,000
Q4 2020 Feb 16, 2021	SELL	$207.01 - $276.09 $6,417 - $8,558	-31 Reduced 1.36%	2,250 $531,000
Q3 2020 Nov 12, 2020	SELL	$255.65 - $303.1 $18,918 - $22,429	-74 Reduced 3.14%	2,281 $620,000
Q2 2020 Aug 14, 2020	BUY	$225.48 - $295.8 $5,637 - $7,395	25 Added 1.07%	2,355 $683,000
Q1 2020 May 06, 2020	BUY	$199.77 - $247.81 $35,958 - $44,605	180 Added 8.37%	2,330 $554,000
Q4 2019 Feb 13, 2020	BUY	$166.71 - $223.91 $41,677 - $55,977	250 Added 13.16%	2,150 $470,000
Q3 2019 Nov 13, 2019	BUY	$166.23 - $187.09 $166,230 - $187,090	1,000 Added 111.11%	1,900 $321,000
Q2 2019 Aug 16, 2019	SELL	$164.61 - $190.37 $4,115 - $4,759	-25 Reduced 2.7%	900 $165,000
Q1 2019 Apr 12, 2019	BUY	$163.73 - $194.7 $16,372 - $19,470	100 Added 12.12%	925 $170,000
Q2 2018 Aug 01, 2018	SELL	$145.72 - $169.96 $218,580 - $254,940	-1,500 Reduced 64.52%	825 $140,000
Q1 2018 Apr 20, 2018	SELL	$151.6 - $177.13 $21,224 - $24,798	-140 Reduced 5.68%	2,325 $378,000
Q4 2017 Jan 22, 2018	BUY	$137.28 - $155.55 $19,219 - $21,777	140 Added 6.02%	2,465 $369,000
Q3 2017 Oct 25, 2017	BUY	$148.13 - $162.24 $344,402 - $377,208	2,325	2,325 $353,000

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $105B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Manhattan CO, based on Form 13F filings with the SEC.

News

Stay updated on First Manhattan CO with notifications on news.

Account

First Manhattan CO Vertex Pharmaceuticals Inc Transaction History